文献速递中枢神经肿瘤放疗放疗物理与技术

脑转移瘤切除术后立体定向放射外科的系统综述与荟萃分析

Post-operative stereotactic radiosurgery following excision of brain metastases: A systematic review and meta-analysis.
PubMed 文献 · Radiother Oncol · 2019-09-25

汇总12个月局部控制率为83.7%,放射性坏死6.9%,柔脑膜播散13%,1年远处脑控制率52.8%;单因素分析显示分次SRS的12个月局部控制率优于单次SRS(87.3% vs 80.0%,p=0.021)。

要点

  • 术后SRS是脑转移瘤切除后安全有效的治疗选择,12个月局部控制率83.7%。
  • 分次SRS较单次SRS的12个月局部控制率更高(87.3% vs 80.0%,p=0.021)。
  • 添加边缘未改善12个月局部控制率(84.3% vs 83.1%,p=0.71)。

核心结论

  • 术后对切除腔行SRS是安全有效的治疗选择,分次SRS可能有益并值得进一步探索。

研究设计与样本

  • 采用DerSimonian-Laird随机效应模型与Mantel-Haenszel加权方案,固定连续性校正0.5,以I2统计量评估异质性。

主要发现

  • 全部研究的12个月局部控制率为83.7%。
  • 单因素分析中分次SRS的12个月局部控制率优于单次SRS(87.3% vs 80.0%,p=0.021)。
  • 添加边缘与未添加边缘的12个月局部控制率无改善(84.3% vs 83.1%,p=0.71)。
  • 全部报告研究中放射性坏死为6.9%,柔脑膜播散为13%。
  • 1年远处脑控制率为52.8%。

临床怎么用

  • 脑转移瘤切除术后可考虑对手术腔行SRS作为安全有效的治疗选择。
  • 分次SRS可能较单次SRS带来更好的局部控制,值得进一步探索。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Following the resection of brain metastases, Stereotactic Radiosurgery (SRS) to the post-operative surgical cavity has increasingly replaced Whole Brain Radiotherapy (WBRT) as the standard of practice. There is however tremendous variation in the way SRS can be delivered and outcomes of SRS are yet to be systemically characterized. METHODS: Pubmed, Medline, Embase, and Cochrane databases were searched through June 2019 to identify papers that examined post-operative SRS after resection of brain metastases. An aggregate data analysis was performed to estimate the pooled rate of local control at 12 months (LC12), radiation necrosis, and leptomengingeal disease dissemination as binary outcomes. We pre-specified a random effects model using the method of DerSimonian and Laird with the Mantel-Haenszel weighting scheme and a fixed continuity correction of 0.5. Heterogeneity was assessed using the I2 statistic. RESULTS: Fifty studies involving 3458 patients were included for analysis. LC12 across all studies was found to be 83.7%. Patients treated with fractionated SRS had better local control than patients treated with single fraction SRS (LC12 87.3% vs 80.0%, p = 0.021) in a univariate analysis. There was no improved LC12 with the addition of a margin (LC12 of 84.3% vs 83.1% with no margin, p = 0.71). Radiation necrosis was rare at 6.9% across all reported studies and leptomeningeal disease was found to be 13% across all reported studies. One year distant brain control was found to be 52.8%. CONCLUSION: Our review supports the use of post-operative SRS to the resection cavity as a safe and efficacious treatment option. Fractionated SRS appears to be beneficial and warrants further exploration.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Akanda ZZ, Hong W, Nahavandi S, et al. Post-operative stereotactic radiosurgery following excision of brain metastases: A systematic review and meta-analysis. Radiother Oncol. 2019. PMID: 31563407. doi:10.1016/j.radonc.2019.08.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。